Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough.

AIDS (London, England) - 24 Sept 2004

Meyohas Marie-Caroline, Lacombe Karine, Carbonne Bruno, Morand-Joubert Laurence, Girard Pierre-Marie

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Multiple, Viral
Share to Enfuvirtide
Share to HIV Envelope Protein gp41

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Fusion Inhibitors

Share to HIV Infections

Share to Peptide Fragments

Share to Pregnancy Complications, Infectious

Source

Identifiers

PMID: 15353987
DOI: 10.1097/00002030-200409240-00017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough.PMID 15353987Read ↗

Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placentaSemantic proximity Read ↗

Enfuvirtide: the first HIV fusion inhibitorSemantic proximity Read ↗

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsSemantic proximity Read ↗

Call to Action: Harmonisation of Pharmacovigilance Regulations for Post-marketing Pregnancy and Breastfeeding Safety StudiesSemantic proximity Read ↗

Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for therapeutic drug monitoring.Semantic proximity Read ↗

Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.Semantic proximity Read ↗

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancySemantic proximity Read ↗

Pharmacogenetics of efavirenz exposure in cervicovaginal fluid during pregnancy and postpartumSemantic proximity Read ↗

CCR5 inhibitors: up and coming new agents.Semantic proximity Read ↗

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVSemantic proximity Read ↗

Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics.Semantic proximity Read ↗

A Case of in utero Transmission of Drug-resistant HIV in the United States.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.